Evidence map›Paper›PMID 42591304›Full record

ArticleFrontiers in medicine2026

Development and internal validation of a nomogram for early prediction of deep vein thrombosis after liver transplantation: an exploratory machine-learning comparison.

Xintao Chen, Wen Luo, Lingxiang Xu, Mingxiang Cheng

Abstract read
In one paragraph

Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Xintao ChenDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wen LuoDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Lingxiang XuDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Mingxiang ChengDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lower-extremity deep vein thrombosis (DVT) after liver transplantation (LT) may delay recovery and complicate thromboprophylaxis. Practical transplant-specific tools for early risk stratification remain limited. Methods: Adult recipients who underwent LT between August 2023 and January 2026 were retrospectively screened. After exclusions, 131 recipients were divided by outcome-stratified random sampling into a training cohort ( Results: DVT occurred in 26 of 131 recipients (19.8%). The logistic model included postoperative ln (D-dimer), anhepatic phase, postoperative activated partial thromboplastin time, and preoperative prothrombin time. Its AUC was 0.79 (95% CI, 0.67-0.90) in the training cohort and 0.81 (95% CI, 0.56-1.00) in the hold-out subset. The 5-fold cross-validated AUC was 0.76 (95% CI, 0.63-0.86), and the bootstrap optimism-corrected AUC was 0.76. Wide, overlapping confidence intervals and model-specific optimism did not support reliable algorithm ranking. Conclusion: A concise logistic regression-based nomogram using routinely available perioperative variables may support early individualized DVT risk estimation after LT. The machine-learning analyses should be regarded as exploratory. Larger prospective multicenter studies are required before clinical implementation.

Indexed as

deep vein thrombosisliver transplantationmachine learningnomogramrisk prediction

Identifiers

PMID42591304
PMCPMC13461469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.